Red pigment in red peppers and oranges linked to a lower risk of lung cancer

January 20, 2017, Tufts University
Researchers find BCX—red pigment abundant in sweet red peppers, paprika, winter and butternut squash, oranges, and tangerines, among other foods—appears to counteract nicotine’s ability to accelerate the growth of lung tumors. Credit: Ingimage

Xiang-Dong Wang, a cancer researcher at Tufts, has spent a long time trying to figure out why carotenoids, the main pigments providing colors that range from yellow and pink to deep orange and red in most fruits and vegetables, seem to keep chronic diseases at bay. When a 2004 study by other researchers showed that eating foods containing beta-cryptoxanthin (BCX)—a red pigment abundant in sweet red peppers, paprika, winter and butternut squash, oranges. and tangerines, among other foods—was associated with a lower risk of lung cancer in people who smoke, he made BCX a focus of his research.

Since then, Wang and his colleagues have been studying how the pigment might work at the molecular level to thwart lung cancer. In their latest study looking at mice and cell models of human lung cancer, published in Cancer Prevention Research, they found that BCX appears to counteract one of the lesser-known abilities of nicotine, which is to accelerate the growth of lung tumors.

Lung cancer continues to be the leading cause of cancer death in the United States, and smoking continues to be the leading cause of lung cancer. "For smokers, tobacco product users or individuals at higher risk for tobacco smoke exposure, our results provide experimental evidence that eating foods high in BCX may have a beneficial effect on lung cancer risk, as suggested by previous epidemiological studies," said Wang, N92, a senior scientist and director of the Nutrition and Cancer Biology Laboratory at the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts. This better understanding of BCX's molecular mechanism could lead to dietary recommendations for patients undergoing chemotherapy for lung cancer and for those who have survived, said Wang, who is also a professor at the Friedman School.

The Tufts study suggests that BCX and nicotine have opposite effects in . Nicotine binds to a specific receptor on the surface of lung cells. This binding triggers many biochemical signaling events that cause cells to proliferate and new blood vessels to develop, two hallmarks of cancer. Nicotine also boosts the cells' production of this specific receptor. With large numbers of those receptors available for nicotine to bind to, lung cancer cells in smokers get an even stronger signal to keep growing.

Wang and his team demonstrated that BCX causes cells to decrease the amount of that specific nicotine receptor on their surfaces, which may dampen cell growth. When the researchers administered daily doses of BCX to mice before and after they injected the rodents with a nicotine-derived carcinogen, they found that the mice treated with BCX had fewer lung tumors than those that got no BCX.

The inhibition of the receptor by BCX may also play a role in keeping cancer from spreading. Malignant cells' ability to move freely about the body is a key requirement for them to metastasize. Wang's team discovered that if human in a lab dish in the presence of the receptor were treated with BCX, they migrated less than untreated ones. In addition, previous studies done in Wang's lab suggest that BCX, through a different molecular mechanism, can slow the nicotine-promoted growth of and decrease cigarette smoke-induced lung inflammation in animal models.

It's the first time nicotine receptors on the surface of lung cells have been linked to BCX, according to Srikumar Chellappan, a cancer biologist at the H. Lee Moffitt Cancer Center & Research Institute in Tampa, Florida. More research is needed to fully understand how BCX slows lung cell production of nicotine receptors, Chellappan said. "A significant amount of molecular studies would be needed to understand how this agent functions in chemoprevention," he noted.

In Wang's experiments, the BCX dose that seemed to have the greatest benefit in mice was equivalent to a daily human dose of about 870 micrograms—the amount contained in one sweet red pepper or a couple of tangerines a day, he said.

He emphasized that eating whole fruits and vegetables, which include other antioxidants and nutrients that can have additive or complementary effects, is better than taking dietary supplements. Several clinical trials over the years have tested various single-nutrient supplements for cancer prevention. Not only did they fail to show any benefit, but some even caused more people to get cancer, he said.

Still, there's no hard evidence to demonstrate that foods containing BCX can prevent lung cancer in people. To gather such data, Wang plans to study the effects of BCX-containing foods in people, particularly smokers with and without .

Explore further: Beta-cryptoxanthin, a carotenoid, inhibits nicotine-linked lung cancer development in mice

Related Stories

Beta-cryptoxanthin, a carotenoid, inhibits nicotine-linked lung cancer development in mice

November 1, 2016
Beta-cryptoxanthin (BCX), a carotenoid pigment compound found primarily in plants, reduces the number and invasiveness of tumors in mouse and cell models of lung cancer, report scientists from the Jean Mayer USDA Human Nutrition ...

Smokers with newly discovered genetic markers have higher lung cancer risk

August 25, 2016
University of Hawai'i Cancer Center researchers have discovered new genetic markers associated with a fast rate of nicotine metabolism, which potentially leads smokers to smoke more, thereby increasing their risk for lung ...

Protein boosts lung cancer in smokers, non-smokers; Potential anti-oncogenic target

July 19, 2011
Lung cancer is strongly correlated with smoking, and most lung cancer patients are current or former smokers. But it is not rare in nonsmokers. Now, a team of researchers from the H. Lee Moffitt Cancer Center and Research ...

Before a cure, a crusade to stop lung cancer from spreading

November 11, 2016
The American Cancer Society has reported that lung cancer, which kills more Americans than any other type of cancer, is expected result in an estimated 158,080 deaths in 2016.

Team discovers protein pathway involved in lung cancer metastasis

January 28, 2015
Smoking is the leading cause of lung cancer, and it is estimated that more than 159,000 people in the United States died from the disease last year. Most of these deaths were because the cancer had spread to other organ sites. ...

Preclinical study suggests E-cigarettes may promote lung cancer in high-risk individuals

January 9, 2014
Exposing human lung cells with genetic mutations associated with high risk for lung cancer to the chemicals in electronic-cigarette (e-cigarette) vapor enhanced the cells' cancerous behaviors, according to preliminary results ...

Recommended for you

Why some cancers affect only young women

October 19, 2018
Among several forms of pancreatic cancer, one of them specifically affects women, often young. How is this possible, even though the pancreas is an organ with little exposure to sex hormones? This pancreatic cancer, known ...

Scientists to improve cancer treatment effectiveness

October 19, 2018
Together with researchers from the University of Nantes and the University of Reims Champagne-Ardenne in France, experts from the National Research Nuclear University MEPhI have recently developed a quantum dot-based microarray ...

Mutant cells colonize our tissues over our lifetime

October 18, 2018
By the time we reach middle age, more than half of the oesophagus in healthy people has been taken over by cells carrying mutations in cancer genes, scientists have uncovered. By studying normal oesophagus tissue, scientists ...

Study involving hundreds of patient samples may reveal new treatment options of leukemia

October 17, 2018
After more than five years and 672 patient samples, an OHSU research team has published the largest cancer dataset of its kind for a form of leukemia. The study, "Functional Genomic Landscape of Acute Myeloid Leukemia", published ...

A 150-year-old drug might improve radiation therapy for cancer

October 17, 2018
A drug first identified 150 years ago and used as a smooth-muscle relaxant might make tumors more sensitive to radiation therapy, according to a recent study led by researchers at The Ohio State University Comprehensive Cancer ...

Loss of protein p53 helps cancer cells multiply in 'unfavourable' conditions

October 17, 2018
Researchers have discovered a novel consequence of loss of the tumour protein p53 that promotes cancer development, according to new findings in eLife.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

Jim4321
not rated yet Jan 20, 2017
It appears that nicotine itself increases the risk of cancer. This is sad news because it means that all nicotine replacement therapies from gum to electronic cigarettes also may have an enhanced tendency towards cancer. The immediate question is then could beta-cryptoxanthin be incorporated in these products to a degree that would cancel the increased risk of cancer. Care is needed as a related carotene, beta-carotene, seems to increase cancer risk in smokers.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.